Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
Clinical trial NCT06145360 · COMPLETED
Trial details
- NCT number
- NCT06145360
- Sponsor
- SINA Health Education and Welfare Trust
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-03-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.